Latest Tiziana Life Sciences News & Updates

See the latest news and media coverage for Tiziana. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Tiziana Life Sciences (Tiziana)

Clinical-stage biopharmaceutical company developing immunotherapies for neurological and inflammatory conditions

tizianalifesciences.com
Headquarters
London, United Kingdom
Company type
Public company
Number of employees
10–50
Industry
Pharmaceuticals

Last updated

Latest news about Tiziana Life Sciences (Tiziana)

In short: Tiziana Life Sciences achieved significant clinical milestones with its lead candidate foralumab in multiple neuroinflammatory diseases.

Company announcements

Tiziana

Tiziana Life Sciences fully enrolls Phase 2 multiple sclerosis trial

The randomized, double-blind, placebo-controlled trial evaluates intranasal foralumab in 48 patients with non-active secondary progressive MS.

Unlock all announcements with a

Media coverage

Stockhouse

Tiziana Life Sciences Granted FDA Fast Track Designation

NEW YORK, July 24, 2024 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies...

Unlock all articles with a

Never miss news about Tiziana

Track Tiziana and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Tiziana competitors & trending companies

Browse news for competitors to Tiziana and other trending companies.